-
Nippon India Pharma IDCW-R
Equity healthcare
Overview ( as on 18/04/24 )
NAV
₹107.03
Last change
₹-0.89 -0.01%
Fund Size (AUM)
7125.28 Cr
Performance
24.86% (5Y)
Fund Details
Nippon India Pharma IDCW-R
as of 18/04/24
AUM
7125.28 Cr
Expense Ratio
1.83 %
Benchmark
S&P BSE Healthcare TR INR
ISIN
INF204K01943
Fund Manager
Sailesh Raj Bhan
Exit Load
1.0% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Pharma IDCW-R | 48.06% | 17.51% | 24.86% |
| S&P BSE Healthcare TR INR | 60.18% | 18.01% | 19.46% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
14.91% |
Lupin Ltd |
8.4% |
Cipla Ltd |
6.51% |
Apollo Hospitals Enterprise Ltd |
5.79% |
Dr Reddy's Laboratories Ltd |
4.75% |
Gland Pharma Ltd |
4.4% |
Divi's Laboratories Ltd |
4.36% |
Zydus Lifesciences Ltd |
4.18% |
J.B. Chemicals & Pharmaceuticals Ltd |
3.44% |
Abbott India Ltd |
3.29% |
Sector Allocation
Healthcare |
100.0% |
Asset Allocation
-
97%
Equity
-
3%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
23.01% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
23.02% (5Y)
-
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
24.18% (5Y)
-
-
Nippon India Pharma IDCW-P
Equity healthcare-
Returns
-
25.0% (5Y)
-
-
Nippon India Pharma IDCW-R
Equity healthcare-
Returns
-
24.86% (5Y)
-
-
Tata India Pharma & Healthcare Reg Gr
Equity healthcare-
Returns
-
22.11% (5Y)
-
